Rearrangements involving the TCF3 (previously known as E2A) gene region (19p13.3) are common in both pediatric and adult B-lymphoblastic leukemia/lymphoma (B-ALL/LBL) and account for ~6% of newly diagnosed cases1–4. The gene discussed is TCF3; the disease is lymphoma.